WO1995019201A1 - Cardiac electrotherapy system with cardiac contraction sequence measurement - Google Patents
Cardiac electrotherapy system with cardiac contraction sequence measurement Download PDFInfo
- Publication number
- WO1995019201A1 WO1995019201A1 PCT/EP1995/000113 EP9500113W WO9519201A1 WO 1995019201 A1 WO1995019201 A1 WO 1995019201A1 EP 9500113 W EP9500113 W EP 9500113W WO 9519201 A1 WO9519201 A1 WO 9519201A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiac
- contraction
- leads
- heart
- electronic circuitry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
Abstract
A cardiac electrotherapy device comprises at least two cardiac electrotherapy leads (151, 157), said leads comprising sensor portions (160, 157) adapted to detect cardiac contractions in two different regions (156, 158) of the heart through a deflection of said leads (151, 157), electronic circuitry (173-181, 185) connected to or connectable to said leads and adapted to generate cardiac contraction data signals (B, C, D) corresponding to a detection by said sensor portions, and cardiac arrhythmia detection means operating in response to said cardiac contraction data signals and capable of detecting cardiac arrhythmia therefrom.
Description
CARDIAC ELECTROTHERAPY SYSTEM WITH CARDIAC CONTRACTION SEQUENCE MEASUREMENT
Field of the Invention
This invention relates to cardiac pacemakers and implantable cardioverters - defibrillators, in general, and to a cardiac electrotherapy device in particular.
Background and Prior Art
A device which has been disclosed in the U.S. Pat.No. 4,790,317 can automatically recognize the pathologic rhythm by means of monitoring of the pulse sequence represent¬ ing the ventricular electrical activity. The disclosed device measures the timing sequence of electrical depolarization of the heart. Different ventricular rhythms can be identified by a specific different ventricular depolarization wave spread. Detection of either epicardial or endocardial potential on at least two different points of ventricular muscle provides a specific timing sequence of ventricular depolarization for every kind of ventricular rhythm. Therefore at least two sensing positions on the ventricles are used, but more sensing points will obtain better discrimination between normal and pathologic rhythms as well as between various pathologic rhythms. If the multiple points ventricular sensing is combined with atrial potential sensing, the specific timing sequence may be obtained in order to detect and discriminate various supraventricular arrhythmias.
U.S. patent No. 5,261,418, U.S. patent No. 5,271,392 and EP 0 473 070 A2 discloses a device for lead tension measurement comprising so-called tensiometric transducers. These transducers may be produced of either the piezoelectric material or the conductive rubber. Both materials may be used for production of tensiometric stylets. In these patent applica¬ tions, there is a possibility to use a standard pacing lead for tensiometric measurement. Normally, the stylet channel of a lead enables the control of the lead implantation by means of a steel wire (stylet) insertion. Manipulating the stylet i.e. rotating, pushing and pulling governs the direction of the lead tip. After the proper positioning of the lead tip,
the stylet is pulled-out. Therefore every implanted lead comprises an empty stylet channel which may be used for the permanent insertion of a stylet which may be used for lead tension measurement. European Pat.No. 461 539 as well as U.S. Pat.No. 4,291,707 specify a tensiometric patch. U.S. Pat. No. 5,109,842 discloses a motion sensor which may be mounted onto the restricted and relatively small area of a defibrillator patch. None of these systems disclose the use of at least two sensors.
It is an object of the present invention to provide an improved device for detecting patho¬ logic tachycardias, and for enabling a more accurate differentiation between various types of tachycardias.
The object is achieved by the cardiac electrotherapy device according to claims 1 or 8. Preferred embodiments are described in the dependent claims.
Summary of the Invention
According to the present invention the device is incorporated within an implantable electrotherapy apparatus in order to achieve the measuring of the mechanical contractions of the heart muscle. Therefore, the mechanical activity of the heart is used for the purpose of the present invention, instead of the electrical activity as described in the prior art.
At least two of the elastic tensiometric strips are mechanically coupled to the heart muscle on the two different positions. Either analysis of the electric signals or measurement of the resistivity variations produced within the multiple tensiometric strips and caused by means of the cardiac muscle contractions, provides monitoring of the mechanical activity of the heart in such a way as to obtain the timing sequence of mechanical contraction of the heart.
The disclosed device yields a detection of the mechanical contraction sequence of the heart
which is characteristic for a certain type of cardiac rhythm, thus enabling exact detection of the pathologic cardiac rhythm as well as differentiation of various cardiac arrhythmias. The device can monitor the ration of amplitudes of at least two tensiometric transducer signals for the purpose of detection of the pathologic cardiac rhythm as well as differentia- tion of various cardiac arrhythmias.
These and other aspects of the present invention will be more readily understood by reference to the following description and accompanying drawings in which
Fig. 1 is a cross-sectional four-chamber view of a human heart having implanted the atrial and the ventricular pacing lead as well as the left ventricular patch.
Fig. 2 discloses the input circuits for the cardiac contraction sequence measurement.
Fig. 3 shows the electrocardiogram and the corresponding output waveforms of circuits from previous Fig..
Description of the Preferred Embodiment
In the embodiment of Fig. 1 there is disclosed a four-chamber cross-section of the human heart having implanted the atrial 150 as well as the ventricular 151 cardiac pacing lead. Both leads enter the right atrium 152 through the superior vena cava 153. The atrial lead is a J-shaped lead comprising an electrode 154 on its tip which is positioned in the right atrial appendage. The ventricular lead has an electrode 155 on its tip which is positioned in the right ventricle 156 in the apical position. Epicardial cardioversion patch 157 is implanted on the left ventricular free wall 158. Though unipolar leads are disclosed, bipolar leads would be also implanted in the same anatomic relation to the heart chambers. Every contraction of the heart muscle deflects both pacing leads as well as the patch. The atrial contraction causes the bending of the atrial lead while the ventricular contraction causes the bending of the ventricular lead as well as of the patch. Magnitude of the lead
deflection depends on the radial lead stiffness and on the heart muscle contraction forces. Magnitude of the patch deflection depends on the patch stiffness and on the heart muscle contraction forces.
The bending segment 159 of the lead 150 implanted in the right atrial appendage is shaded gray, as well as it is the bending segment 160 of the ventricular lead 151. Because the patch 157 is fixed with its entire body to the left ventricular wall 158, the entire patch is bended by the left ventricular wall contraction. Actually, the ventricular lead bending forces are mainly caused by the right ventricular contraction. Therefore the timing sequence between the ventricular lead 151 bending and epicardial patch 157 bending corresponds to the timing sequence between the right ventricular and left ventricular contraction. In normal sinus rhythm or in rhythm of ventricular pacing, there will be always some delay of patch 157 bended relatively to the ventricular lead 151 bending. In ventricular tachycardia, this delay may be changed or even inverted in the manner that patch 157 is bending first and then lead 151 after certain delay. If leads and patch are tensiometric, such as disclosed in U.S. Patent No. 5,261,418, the signals of tensiometric transducers will provide the timing sequence of cardiac mechanical contraction.
In the embodiment of Fig. 2, there is disclosed a block diagram of the input circuit for cardiac contraction sequence measurement by means of tensiometric leads and tensiometric patch implanted as disclosed in previous Fig. 1. The tensiometric transducers of the atrial lead 170, ventricular lead 171 and ventricular patch 172 are connected to the correspond¬ ing amplifiers 173, 174 and 175, respectively. The outputs of the amplifiers 173, 174 and 175 are connected to the voltage comparators 176, 177 and 178, respectively. The outputs of the comparators 176, 177 and 178 are connected to the inputs of retriggerable mono- stable multivibrators 179, 180 and 181, respectively. The output 182 of multivibrator 179 provides a pulse representing the moment of atrial lead tension, i.e. right atrial appendage contraction. The output 183 of multivibrator 180 provides a pulse representing the moment of ventricular lead tension, i.e. right ventricular contraction. The output 184 of multivibrator 181 provides a pulse representing the moment of ventricular patch tension,
i.e. left ventricular contraction. Reference voltage for comparators is generated by means of a precise programmable voltage level source 185.
In the embodiment of Fig. 3, there are disclosed the waveforms of electrocardiogram and corresponding output pulses from multivibrators 179, 180 and 181. Waveform A shows the electrocardiogram having P-wave 190, QRS complex 191 and T-wave 192. Waveform B are the pulses provided at the output 182, designating the occurence 193 of the artrial appendage contraction. Waveform C are the pulses provided at the output 183, designat¬ ing the occurrence 194 of the right ventricular contraction. Waveform D are the pulses provided at the output 184, designating the occurrence 195 of the left ventricular contrac¬ tion at the site of patch implantation. Pulse 193 occurs after certain delay succeeding the P-wave 190 which is a normal delay of the cardiac muscle contraction after the cardiac muscle depolarization. Because of the same reason, pulses 194 and 195 occur after certain delay succeeding the QRS complex 191. There is a slight delay interval 196 of pulse 195 after the pulse 194 which is the delay of left ventricular patch tension after d e ventricular lead tension. Delay interval 196 usually increases if ventricular tachycardia occurs, but may be also vice versa. Different delay interval durations distinguish different ventricular tachycardias. In certain ventricular tachycardias pulse 195 may occur before the pulse 194. There are two tensiometric atrio-ventricular intervals 197 and 198. In the case of supraventricular tachycardia, these atrio-ventricular intervals change, a specific tachycardia having characteristic ration of these two atrio-ventricular intervals duration. Therefore every cardiac rhythm, either natural of pathologic may be defined by means of three tensiometric intervals 196, 197 and 198. This means that every cardiac rhythm has a distinctive sequence of pulses 193, 194 and 195. Measurement of this sequence is used for tachycardia detection and differentiation between various types of tachycardias.
It is understood that the outputs 182, 183 and 184 are connected to the microprocessor of an electrotherapy device. Specific pulses sequence for specific tachycardia is memorized within the microprocessor memory during intentionally provoked episode of tachycardia in electrophysiologic study session. Detection of the specific pulses sequence, within the
certain allowed margins of timing accuracy, may initiate a certain antiarrhythmic mode of electrotherapy.
Fig. 2 can also illustrate completely another possible embodiment of the present invention. As it is known in the art, the outputs of amplifiers 173, 174, and 175 could be also connected to sample-and-hold circuits 176, 177 and 178, as well as to the analog to digital convenors 179, 180 and 181. In that kind of embodiment, the outputs 182, 183 and 184 would be connected to the digital input ports (not disclosed) in order to supply a micropro¬ cessor circuit (not disclosed) with digital form of tensiometric transducers' signals. In such kind of device, the voltages produced by transducers 170, 171 and 172 could be measured and compared by means of the appropriate software. Some tachycardias decrease the magnitude of the contraction at the certain region of the cardiac muscle. Some tachycardias change the ratio of magnitudes of contractions of the two different regions. The output voltage amplitude of the piezoelectric transducer is proportional to the magnitude of the cardiac contraction being measured by the transducer. Accordingly, mutual rations of voltage amplitudes generated by the transducers 170, 171 and 172 represent the mutual rations of magnitudes of the tensions of leads 150 and 151 as well as of patch 157. For instance, the ration of voltages generated by the transducers 171 and 172 represents the certain ventricular rhythm. It will be significantly different in ventricu- lar tachycardia, compared with the sinus rhythm. Moreover, it will be different in two ventricular tachycardias having different electrophysiologic origin. Furthermore, the ration of voltages generated by transducers 170 and 171 will be significantly different in supra¬ ventricular tachycardia compared to the sinus rhythm.
The electrotherapy device having both disclosed measurement systems i.e. contraction sequence and regional contraction magnitude ratio variation would have a powerful means for cardiac arrhythmias recognition and classification.
Although I have described my invention in detail with reference to the accompanying drawing illustrating preferred embodiments of my invention, it is understood that numerous
changes in the details of construction and arrangements of parts may be made without departing from the spirit and scope of the invention as hereinafter claimed.
Claims
1. A cardiac electrotherapy device comprising: at least two cardiac electrotherapy leads (151, 157), said leads comprising sensor portions (160, 157) adapted to detect cardiac con¬ tractions in two different regions (156, 158) of the heart through a deflection of said leads (151, 157), electronic circuitry (173-181, 185) connected to or connectable to said leads and adapted to generate cardiac contraction data signals (B, C, D) corresponding to a detection by said sensor portions, and cardiac arrhythmia detection means operating in response to said cardiac contraction data signals and capable of detecting cardiac arrhythmia therefrom.
2. Device according to claim 1, comprising means for terminating cardiac arrhythmia, and electronic circuitry for cardiac electrotherapy.
3. Device according to claim 1 or 2, wherein each of said leads (151, 157) comprises a transducer (171, 172) generating a signal having an amplitude proportional to the magnitude of cardiac contraction at the cardiac region wherein said lead is implanted (156) or whereon said lead is attached (158), said signal occurring at the onset (194, 195) of cardiac contraction of the cardiac region wherein said lead is implanted (156) or whereon said lead is attached (157).
4. Device according to any of claims 1 to 3, wherein said electronic circuitry for generating cardiac contraction data signals comprises means for calculation of a time interval (196) representing the contraction timing between said two regions of the heart (156, 158), means for beat to beat comparation of said time interval, and means for detection of sudden change of duration of said time interval in a single beat, said sudden change indicating that said single heart beat is a ventricular premature contraction.
5. Device according to claim 4, wherein said electronic circuitry for generating cardiac contraction data signals comprises means for detection of sudden change of duration of said time interval in a series of heart beats, said sudden change indicating the initiation of cardiac arrhythmia and activating said means for terminating cardiac arrhythmia.
6. Device according to claim 3, wherein said electronic circuitry for generating cardiac contraction data signals comprises means for amplitude measurement of the two signals of said transducers, means for beat to beat comparation of said amplitudes and means for detection of sudden change of ratio of said amplitudes in a single beat, said sudden change indicating that said single heart beat is a ventricular premature contraction.
7. Device according to claims 6, wherein said electronic circuitry for generat¬ ing cardiac contraction data signals comprises means for detection of sudden change of ration of said amplitudes in a series of beats, said sudden change indicating the initiation of cardiac arrhythmia and activating said means for terminating cardiac arrhythmia.
8. A cardiac electrotherapy device comprising at least two cardiac electrotherapy leads (151, 157) capable to measure cardiac contractions, electronic circuitry for cardiac electrotherapy and electronic circuitry for cardiac contractions measurement, timing and processing of the cardiac contractions data of the two different regions of the heart (156, 158), said device comprising means for cardiac arrythmia detection and means for terminating cardiac arrythmia, wherein said means are controlled by means of processing of the signals generated within said leads (151, 157) by cardiac contractions at the two different regions of the heart (156, 158).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HRP940023A | 1994-01-12 | ||
HRP940023 HRP940023A2 (en) | 1994-01-12 | 1994-01-12 | Apparatus for cardial electrotherapy with a system for measuring a sequence of cardial contractions |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995019201A1 true WO1995019201A1 (en) | 1995-07-20 |
Family
ID=10946065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1995/000113 WO1995019201A1 (en) | 1994-01-12 | 1995-01-12 | Cardiac electrotherapy system with cardiac contraction sequence measurement |
Country Status (2)
Country | Link |
---|---|
HR (1) | HRP940023A2 (en) |
WO (1) | WO1995019201A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000002612A2 (en) | 1998-07-10 | 2000-01-20 | Medtronic, Inc. | Medical device and method for transmyocardial revascularization |
EP2189182A1 (en) * | 2008-11-19 | 2010-05-26 | Ela Medical | Implantable active medical device comprising means for atrial capture testing |
WO2011008748A3 (en) * | 2009-07-15 | 2011-11-17 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
US8285373B2 (en) | 2009-07-15 | 2012-10-09 | Cardiac Pacemakers, Inc. | Remote sensing in an implantable medical device |
US8588906B2 (en) | 2009-07-15 | 2013-11-19 | Cardiac Pacemakers, Inc. | Physiological vibration detection in an implanted medical device |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2166812A5 (en) * | 1971-11-26 | 1973-08-17 | Medtronic Inc | |
US4291707A (en) * | 1979-04-30 | 1981-09-29 | Mieczyslaw Mirowski | Implantable cardiac defibrillating electrode |
WO1987001947A1 (en) * | 1985-10-07 | 1987-04-09 | Thomas Jefferson University | Myocardial contractility-sensitive pacer and method |
EP0264666A1 (en) * | 1986-09-30 | 1988-04-27 | Pacesetter AB | Activity sensor for a cardiac pace-maker |
US4790317A (en) * | 1985-10-25 | 1988-12-13 | Davies David W | Apparatus for recognition and termination of ventricular tachycardia and ventricular fibrillation |
EP0461539A2 (en) * | 1990-06-13 | 1991-12-18 | Pacesetter AB | Electrode assembly for defibrillator |
EP0473070A2 (en) * | 1990-08-24 | 1992-03-04 | Bozidar Ferek-Petric | Cardiac pacing systems with tensiometry |
EP0474957A2 (en) * | 1990-09-11 | 1992-03-18 | Bozidar Ferek-Petric | Ultrasonic doppler synchronized cardiac electrotherapy device |
US5109842A (en) * | 1990-09-24 | 1992-05-05 | Siemens Pacesetter, Inc. | Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system |
US5271392A (en) * | 1990-08-24 | 1993-12-21 | Siemens-Elema Ab | Method and apparatus for administering cardiac electrotherapy dependent on mechanical and electrical cardiac activity |
-
1994
- 1994-01-12 HR HRP940023 patent/HRP940023A2/en not_active Application Discontinuation
-
1995
- 1995-01-12 WO PCT/EP1995/000113 patent/WO1995019201A1/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2166812A5 (en) * | 1971-11-26 | 1973-08-17 | Medtronic Inc | |
US4291707A (en) * | 1979-04-30 | 1981-09-29 | Mieczyslaw Mirowski | Implantable cardiac defibrillating electrode |
WO1987001947A1 (en) * | 1985-10-07 | 1987-04-09 | Thomas Jefferson University | Myocardial contractility-sensitive pacer and method |
US4790317A (en) * | 1985-10-25 | 1988-12-13 | Davies David W | Apparatus for recognition and termination of ventricular tachycardia and ventricular fibrillation |
EP0264666A1 (en) * | 1986-09-30 | 1988-04-27 | Pacesetter AB | Activity sensor for a cardiac pace-maker |
EP0461539A2 (en) * | 1990-06-13 | 1991-12-18 | Pacesetter AB | Electrode assembly for defibrillator |
EP0473070A2 (en) * | 1990-08-24 | 1992-03-04 | Bozidar Ferek-Petric | Cardiac pacing systems with tensiometry |
US5261418A (en) * | 1990-08-24 | 1993-11-16 | Siemens Aktiengesellschaft | Cardiac lead with tensiometric element for providing signals corresponding to heart contractions |
US5271392A (en) * | 1990-08-24 | 1993-12-21 | Siemens-Elema Ab | Method and apparatus for administering cardiac electrotherapy dependent on mechanical and electrical cardiac activity |
EP0474957A2 (en) * | 1990-09-11 | 1992-03-18 | Bozidar Ferek-Petric | Ultrasonic doppler synchronized cardiac electrotherapy device |
US5109842A (en) * | 1990-09-24 | 1992-05-05 | Siemens Pacesetter, Inc. | Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1020202A2 (en) | 1998-07-10 | 2000-07-19 | Medtronic, Inc. | Medical device for transmyocardial revascularization |
EP1029511A1 (en) | 1998-07-10 | 2000-08-23 | Medtronic, Inc. | Medical device for transmyocardial revascularization |
WO2000002612A2 (en) | 1998-07-10 | 2000-01-20 | Medtronic, Inc. | Medical device and method for transmyocardial revascularization |
US8214036B2 (en) | 2008-11-19 | 2012-07-03 | Sorin Crm S.A.S. | Atrial capture test for an active implantable medical device |
EP2189182A1 (en) * | 2008-11-19 | 2010-05-26 | Ela Medical | Implantable active medical device comprising means for atrial capture testing |
US8515534B2 (en) | 2009-07-15 | 2013-08-20 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
US8285373B2 (en) | 2009-07-15 | 2012-10-09 | Cardiac Pacemakers, Inc. | Remote sensing in an implantable medical device |
US8301241B2 (en) | 2009-07-15 | 2012-10-30 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
WO2011008748A3 (en) * | 2009-07-15 | 2011-11-17 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
US8588906B2 (en) | 2009-07-15 | 2013-11-19 | Cardiac Pacemakers, Inc. | Physiological vibration detection in an implanted medical device |
US8626281B2 (en) | 2009-07-15 | 2014-01-07 | Cardiac Pacemakers, Inc. | Remote sensing in an implantable medical device |
US8700146B2 (en) | 2009-07-15 | 2014-04-15 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
US8862226B2 (en) | 2009-07-15 | 2014-10-14 | Cardiac Pacemakers, Inc. | Remote sensing in an implantable medical device |
US8934970B2 (en) | 2009-07-15 | 2015-01-13 | Cardiac Pacemakers, Inc. | Physiological vibration detection in an implanted medical device |
US8942799B2 (en) | 2009-07-15 | 2015-01-27 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
US9381358B2 (en) | 2009-07-15 | 2016-07-05 | Cardiac Pacemakers, Inc. | Remote detection of physiological parameter using an implantable medical device |
US9867987B2 (en) | 2009-07-15 | 2018-01-16 | Cardiac Pacemakers, Inc. | Remote detection of physiological parameter using an implantable medical device |
Also Published As
Publication number | Publication date |
---|---|
HRP940023A2 (en) | 1996-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10449365B2 (en) | Determining onsets and offsets of cardiac depolarization and repolarization waves | |
US7627368B2 (en) | Method and apparatus for atrial arrhythmia detection | |
US9572505B2 (en) | Determining onsets and offsets of cardiac depolarization and repolarization waves | |
US5817134A (en) | Apparatus and method for detecting atrial fibrillation by morphological analysis | |
US4674509A (en) | System and method for detecting evoked cardiac contractions | |
US7787951B1 (en) | System and method for determining optimal stimulation sites based on ECG information | |
EP2100553B1 (en) | Apparatus and method to assess the risk of R-on-T event | |
US7149573B2 (en) | Method and apparatus for impedance signal localizations from implanted devices | |
JP4165684B2 (en) | Automatic threshold sensitivity adjustment for cardiac rhythm management devices | |
EP0220916A2 (en) | Apparatus for recognition of ventricular tachycardia and ventricular fibrillation and for termination thereof | |
US8340768B2 (en) | Sensing threshold control to limit amplitude tracking | |
JPH06502778A (en) | Electronic capture detection for pacemakers | |
JPH06190066A (en) | Heart stimulation device | |
WO2000078391A1 (en) | Multi-site impedance sensor using coronary sinus/vein electrodes | |
KR20010089640A (en) | Antitachycardial pacing | |
EP2389107A1 (en) | A "blurred template" approach for arrhythmia detection | |
US8437837B2 (en) | Method and apparatus for induced T-wave alternans assessment | |
Pannizzo et al. | Automatic methods for detection of tachyarrhythmias by antitachycardia devices | |
EP0656219B1 (en) | Analysis device for analyzing electrical signals from a heart | |
WO1995019201A1 (en) | Cardiac electrotherapy system with cardiac contraction sequence measurement | |
Donaldson et al. | The ventricular endocardial paced evoked response | |
CN107072579B (en) | Atrial arrhythmia detection during intermittent ventricular pacing conditions in a cardiac medical device | |
Aubert et al. | Automatic detection of ventricular tachycardia and fibrillation using ECG processing and intramyocardial pressure measurement | |
US11304647B2 (en) | Dynamic control of sensitivity associated with detecting R-waves | |
Mitchell et al. | Recordings of basal ventricular preexcitation from electrode catheters in patients with accessory atrioventricular connections. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |